Business Standard

Alkem Laboratories Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Reply To BSE Email - Additional Details Required Under SEBI Circular Dated July 13 2023 For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015. Please find attached herewith our response with respect to your email dated 12th...Read More12/04/2024
Compliances- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St March 2024. In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Require...Read More11/04/2024
Compliance Certificate For The Period Ended March 2024. With reference to the subject matter please find enclosed herewith the Complianc...Read More10/04/2024
Reply To BSE Limited - Outcome Of The 49Th Annual General Meeting Of The Company. With reference to the captioned subject please find attached herewith the update...Read More08/04/2024
Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order Pursuant to Regulation 30 of SEBI LODR this is to inform you that the Company ha...Read More08/04/2024
Shareholder Meeting / Postal Ballot-Scrutinizers Report Please find enclosed herewith the details regarding the voting results of the bu...Read More08/04/2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot Please find attached herewith the details regarding the voting results of the bu...Read More08/04/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More01/04/2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Incorporation Of A Wholly Owned Subsidiary Of The Company Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations 2...Read More28/03/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release This is to inform you that USFDA had conducted an inspection at the Companys man...Read More27/03/2024
Closure of Trading Window This is to inform you that the trading window will remain closed from 30th March...Read More27/03/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation With reference to relevant provisions of SEBI (Listing Obligations and Disclosur...Read More22/03/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Please find enclosed the details of investor meet scheduled on 20th March 2024.15/03/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation With reference to relevant provisions of SEBI (Listing Obligations and Disclosur...Read More13/03/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation With reference to relevant provisions of SEBI (Listing Obligations and Disclosur...Read More13/03/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation With reference to relevant provisions of SEBI (Listing Obligations and Disclosur...Read More13/03/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Please find enclosed herewith a copy of advertisement published in todays newspa...Read More07/03/2024
Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order Pursuant to Regulation 30 of SEBI LODR this is to inform you that the Company ha...Read More07/03/2024
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot In furtherance to our intimation dated 09th February 2024 and pursuant to the ap...Read More06/03/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release This is to inform you that US FDA has issued an Establishment Inspection Report...Read More28/02/2024

Load more